miRNA-6515-5p regulates particulate matter-induced inflammatory responses by targeting CSF3 in human bronchial

Eun Suk Son1, Ui Won Ko2, Hee-Yeon Jeong2

  • 1Department of Medicine, College of Medicine, Gachon University, Incheon, Republic of Korea.

Insights

Particulate matter (PM10) triggers respiratory inflammation by downregulating miR-6515-5p. This microRNA targets CSF3, inhibiting the MAPK/ERK pathway and reducing inflammatory responses in bronchial cells.

Area of Science:

  • Pulmonary Medicine
  • Molecular Biology
  • Environmental Health

Background:

  • Particulate matter (PM) exposure is linked to respiratory diseases, but its precise molecular inflammatory mechanisms remain elusive.
  • Understanding the role of microRNAs (miRNAs) in PM-induced inflammation is crucial for developing targeted therapies.

Purpose of the Study:

  • To elucidate the molecular mechanisms underlying PM10-mediated inflammation in bronchial epithelial cells.
  • To identify key miRNAs and their target genes involved in the inflammatory response to PM10.

Main Methods:

  • Next-generation sequencing to identify differentially expressed miRNAs and mRNAs in PM10-exposed bronchial cells.
  • miRNA mimic and inhibitor transfections to modulate miR-6515-5p levels.
  • Luciferase reporter assays to confirm target gene interactions.
  • Small interfering RNA (siRNA) to inhibit target gene expression.

Main Results:

  • PM10 exposure significantly downregulated miR-6515-5p in human bronchial epithelial cells (BEAS-2B).
  • miR-6515-5p directly targets colony stimulating factor 3 (CSF3), regulating its mRNA and protein levels.
  • Overexpression of miR-6515-5p suppressed PM10-induced inflammation via MAPK/ERK pathway inactivation; inhibition exacerbated it via ERK activation.
  • Inhibition of CSF3 reduced PM10-induced inflammatory markers by inactivating the MAPK/ERK pathway.

Conclusions:

  • miR-6515-5p acts as a crucial regulator of PM10-induced inflammation in bronchial epithelial cells.
  • The miR-6515-5p/CSF3 axis modulates inflammatory responses through the MAPK/ERK signaling pathway.
  • Targeting this pathway offers a potential therapeutic strategy for PM-related respiratory diseases.